Clinical Trial Patients Barely Protected By FDA: Study

Law360, New York (September 28, 2007, 12:00 AM EDT) -- The millions of patients that enroll in clinical trials for experimental drugs and medical devices each year are rarely watched over or protected by the U.S. Food and Drug Administration, a federal investigator has found.

Federal health officials were unaware of how many clinical trials were taking place, audited less than 1% of all testing sites and were usually late to the scene, appearing only when the tests were done, according to a report released Friday by Inspector General Daniel R. Levinson of the Department of...
To view the full article, register now.